Comparative study of subcutaneous versus intravenous IgG replacement therapy in pediatric patients with primary immunodeficiency diseases: A multicenter study in Argentina

Purpose: Several studies have shown that subcutaneous immunoglobulin (SCIG) infusions demonstrate similar efficacy to intravenous Ig (IVIG) in preventing infections in patients with primary immunodeficiency diseases (PID), and are safe and well tolerated in this population. This open, prospective/ r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bezrodnik, L., Gómez Raccio, A., Belardinelli, G., Regairaz, L., Díaz Ballve, D., Seminario, G., Moreira, I., Riganti, C., Cantisano, C., Díaz, H., Di Giovanni, D.
Formato: JOUR
Materias:
Argentina
Beriglobina P
children
immunoglobulin therapy
intravenous
primary immunodeficiency
subcutaneous
human immunoglobulin
adolescent
adult
article
child
clinical article
clinical trial
comparative study
controlled study
drug efficacy
drug safety
drug self administration
drug tolerability
female
fever
headache
human
immune deficiency
immunoglobulin blood level
infection rate
infusion related reaction
injection site erythema
injection site pain
injection site pruritus
injection site swelling
male
multicenter study
nausea
open study
preschool child
priority journal
prospective study
retrospective study
school child
severe combined immunodeficiency
X linked agammaglobulinemia
Adolescent
Child
Feasibility Studies
Female
Humans
Immunoglobulin G
Immunoglobulins, Intravenous
Immunologic Deficiency Syndromes
Immunotherapy
Infection
Injections, Subcutaneous
Male
Prospective Studies
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_02719142_v33_n7_p1216_Bezrodnik
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Ejemplares similares